Company: CERO
Filing Date: 2025-11-17
Form Type: PRE 14A
Source: 0001213900-25-111175
Chunk: 32

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-17
Form: PRE 14A
Chunk 32
---
 procedures set forth in Section 4(e) of the COD, including the application of the “Alternate Conversion Price” in lieu of the conversion price and (iii) the adjustment of the conversion price upon certain issuances of securities below such conversion price after the receipt of the stockholder approval sought by this proposal, as well as the adjustment upon receipt of such stockholder approval for any such issuances below the conversion price that occurred prior to such stockholder approval. The Alternate Conversion procedures apply (i) at any time following the Stockholder Approval Date (as defined in the COD), at the option of the holder or (ii) at any time following the Stockholder Approval Date following 17 the occurrence or during the continuance of a Triggering Event (as defined in the COD) until 10 trading days after such Triggering Event has been cured and permit the conversion of the Series E Preferred Stock at the “Alternate Conversion Price”. “Triggering Events” include the breach of covenants set forth in the COD, including, but not limited to, with respect to the Company’s obligation to file and maintain the effectiveness of a resale registration statement for the underlying shares of Common Stock, maintain the listing of the Common Stock on a nationally recognized securities exchange or deliver shares of Common Stock upon conversion of the Series E Preferred Stock within the required time period, as well as certain court judgments or defaults under outstanding indebtedness or events of bankruptcy or insolvency. The “Alternate Conversion Price” is either (i) the Alternate Optional Conversion Price (as defined in the COD) which is the lower of the then -currentconversion price and the greater of (a) the floor price of $1.00 (the “Floor Price”) and 95% of the lowest volume -weightedaverage price of the Common Stock during the five consecutive trading day period prior to the conversion date, or (jj) the Alternative Triggering Event Conversion Price (as defined in the COD) which is the lower of the then -currentconversion price and the greater of (a) the Floor Price and 90% of the lowest volume -weightedaverage price of the Common Stock during the five consecutive trading day period prior to the conversion date. The Alternate Conversion procedures also result in the application of a 125% Required Premium (as defined in the COD) added to the value of the Series E Preferred Stock converted. As a result, following a decline in the trading price of the Common Stock when the Alternate Conversion procedures are in effect, the Series E Preferred Stock may be convertible at a